Specialists of the domestic pharmaceutical company Farmak have developed and brought to market a drug for the treatment of severe conditions, chronic cerebrovascular disorders and mental activity disorders – Gliaton (choline alfoscerate). The new drug is produced in the form of a solution for injection in 1000 mg ampoules No. 5.
Farmak is actively working in the sphere of treatment of cardiovascular diseases. In particular, much attention is given to ensure comprehensive effective and affordable treatment of severe and chronic cerebrovascular disorders and mental activity disorders. To achieve this objective, the company's specialists have developed and brought to market the drug product Gliaton (choline alfoscerate).
Gliaton is indicated in the acute phase of craniocerebral trauma, in impaired consciousness, coma, focal hemispheric symptoms; degenerative involutional psychoorganic syndromes, cerebrovascular insufficiency; primary and secondary mental disorders, memory impairment, confusion and disorientation. The drug is also indicated in emotional instability, irritability, indifference; pseudo melancholy in the elderly.
Gliaton is the drug that “awakens” (brings) patients out of comas, improves patients’ quality of life: improves memory, mental activity after injuries or as a result of cerebrovascular insufficiency.
The course of treatment with the drug is 2-3 weeks.
The Australian market is considered well-regulated – at the same level as the US and the EU. Therefore, only few Ukrainian companies have the opportunity to supply their products to this country. The share of sales to Australia and Oceania in Ukrainian exports of pharmaceutical products is only 0.3%. “Today, Farmak is about the only […]
Every year, on the 2nd Thursday of November, many countries celebrate the World Quality Day. It was first held in 1990 at the initiative of the European Organization for Quality (an independent non-profit association that brings together 40 national quality organizations in European countries) with the support of the United Nations. Subsequently, the week th...
The 6th Conference of Farmak School of Young Scientists was held on 1 November 2018. 130 guests and employees of Farmak JSC attended the event; 26 reports were presented. This conference already enjoys popularity among students, young scientists, and post-graduate students. The School of Young Scientists is a platform for presenting scientific achievements a...